RE:RE:New Press Release - ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer's Disease"When?" Exactly, nothing says wait for the other shoe to drop (financing) quite like not hearing the other shoe drop (when).